Larimar Therapeutics
LRMR
LRMR
62 hedge funds and large institutions have $47M invested in Larimar Therapeutics in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 69 → 62 (-7)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
Holders
62
Holding in Top 10
–
Calls
$47K
Puts
$7K
Top Buyers
| 1 | +$1.97M | |
| 2 | +$1.34M | |
| 3 | +$900K | |
| 4 |
6CM
683 Capital Management
New York
|
+$358K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$236K |
Top Sellers
| 1 | -$822K | |
| 2 | -$649K | |
| 3 | -$561K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$510K |
| 5 |
ECM
Element Capital Management
New York
|
-$316K |